These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17571362)

  • 1. [Catecholamines use in patients with heart failure].
    Iino K; Ito H
    Nihon Rinsho; 2007 May; 65 Suppl 5():30-3. PubMed ID: 17571362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Currently used positive inotropic substances].
    Hauf GF; Grom E
    Ther Umsch; 1984 Feb; 41(2):111-6. PubMed ID: 6369614
    [No Abstract]   [Full Text] [Related]  

  • 3. [How is catecholamine therapy carried out in heart failure?].
    Reek S
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2087-8. PubMed ID: 12373645
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
    Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
    Seguin P; Bellissant E; Le Tulzo Y; Laviolle B; Lessard Y; Thomas R; Mallédant Y
    Clin Pharmacol Ther; 2002 May; 71(5):381-8. PubMed ID: 12011824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
    Zhou SX; Qiu HB; Huang YZ; Yang Y; Zheng RQ
    Acta Pharmacol Sin; 2002 Jul; 23(7):654-8. PubMed ID: 12100762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined medication of nitroprusside and dopamine or dobutamine in acute heart failure].
    Ye JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):252-4. PubMed ID: 6544205
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of increasing infusion rates of dopamine, dobutamine, epinephrine, and phenylephrine in healthy anesthetized cats.
    Pascoe PJ; Ilkiw JE; Pypendop BH
    Am J Vet Res; 2006 Sep; 67(9):1491-9. PubMed ID: 16948591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient dobutamine-mediated pulsus alternans.
    Kahn JH; Starling MR; Supiano MA
    Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dopamine in "kidney-friendly" doses].
    Olsen NV; Bonde J
    Ugeskr Laeger; 2000 May; 162(20):2864-7. PubMed ID: 10860423
    [No Abstract]   [Full Text] [Related]  

  • 12. [Catecholamines--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
    Kagaya Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():25-9. PubMed ID: 17571361
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological correction of low cardiac output syndrome in hemofiltration].
    Nikiforov IuV; Lebedeva RN
    Anesteziol Reanimatol; 1997; (3):87-9. PubMed ID: 9289999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital video-microscopy analysis.
    Nacul FE; Guia IL; Lessa MA; Tibiriçá E
    Anesth Analg; 2010 Feb; 110(2):547-54. PubMed ID: 20081137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine in heart failure.
    Chatterjee K; Bendersky R; Parmley WW
    Eur Heart J; 1982 Dec; 3 Suppl D():107-14. PubMed ID: 6761125
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination therapy; dobutamine and milrinone].
    Kato M; Hirayama A
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():428-33. PubMed ID: 22724242
    [No Abstract]   [Full Text] [Related]  

  • 18. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine treatment for shock--equally good or bad?
    Singer M
    Lancet; 2007 Aug; 370(9588):636-7. PubMed ID: 17719998
    [No Abstract]   [Full Text] [Related]  

  • 20. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.